Pre-Dialytic SpO2 Measured with a Wearable Device as a Predictor of Mortality in Patients with OSA and Chronic Kidney Disease

Hypoxemia and obstructive sleep apnea (OSA) have been recognized as a threat to life. Nonetheless, information regarding the association between pre-dialytic pulse oximeter saturation (SpO2) level, OSA and mortality risks remains mysterious in patients with maintenance hemodialysis (MHD). Bioclinica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hsiao-Wei Lu, Pin-Hung Kuo, Cheuk-Sing Choy, Chih-Yu Hsieh, Jia-Feng Chang, Mai-Szu Wu, Jing-Quan Zheng, Jian-Chiun Liou
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
LED
T
Acceso en línea:https://doaj.org/article/4f4ba22a47f44d2eb9f7c3df3f359cff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4f4ba22a47f44d2eb9f7c3df3f359cff
record_format dspace
spelling oai:doaj.org-article:4f4ba22a47f44d2eb9f7c3df3f359cff2021-11-25T16:34:57ZPre-Dialytic SpO2 Measured with a Wearable Device as a Predictor of Mortality in Patients with OSA and Chronic Kidney Disease10.3390/app1122106742076-3417https://doaj.org/article/4f4ba22a47f44d2eb9f7c3df3f359cff2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-3417/11/22/10674https://doaj.org/toc/2076-3417Hypoxemia and obstructive sleep apnea (OSA) have been recognized as a threat to life. Nonetheless, information regarding the association between pre-dialytic pulse oximeter saturation (SpO2) level, OSA and mortality risks remains mysterious in patients with maintenance hemodialysis (MHD). Bioclinical characteristics and laboratory features were recorded at baseline. Pre-dialytic SpO2 was detected using a novel microchip LED oximetry, and the Epworth Sleepiness Scale (ESS) score greater than 10 indicated OSA. Non-adjusted and adjusted hazard ratios (aHRs) of all-cause and cardiovascular (CV) mortality were analyzed for pre-dialytic SpO2, OSA and potential risk factors. During 2152.8 patient-months of follow-up, SpO2 was associated with incremental risks of all-cause and CV death (HR: 0.90 (95% CI: 0.82–0.98) and 0.88 (95% CI: 0.80–0.98), respectively). The association between OSA and CV mortality was significant (HR: 3.19 (95% CI: 1.19–9.38). In the multivariate regression analysis, pre-dialytic SpO2 still had an increase in all-cause and CV death risk (HR: 0.88 (95% CI: 0.79–0.98), 0.82 (95% CI: 0.71–0.96), respectively). Considering the high prevalence of silent hypoxia in the post COVID-19 era, a lower pre-dialytic SpO2 level and severe OSA warn clinicians to assess potential CV risks. In light of clinical accessibility, the microchip LED oximetry could be developed as a wearable device within smartphone technologies and used as a routine screen tool for patient safety in the medical system.Hsiao-Wei LuPin-Hung KuoCheuk-Sing ChoyChih-Yu HsiehJia-Feng ChangMai-Szu WuJing-Quan ZhengJian-Chiun LiouMDPI AGarticlepulse oximetryobstructive sleep apneacardiovascular mortalityLEDwearable devicehemodialysisTechnologyTEngineering (General). Civil engineering (General)TA1-2040Biology (General)QH301-705.5PhysicsQC1-999ChemistryQD1-999ENApplied Sciences, Vol 11, Iss 10674, p 10674 (2021)
institution DOAJ
collection DOAJ
language EN
topic pulse oximetry
obstructive sleep apnea
cardiovascular mortality
LED
wearable device
hemodialysis
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
spellingShingle pulse oximetry
obstructive sleep apnea
cardiovascular mortality
LED
wearable device
hemodialysis
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
Hsiao-Wei Lu
Pin-Hung Kuo
Cheuk-Sing Choy
Chih-Yu Hsieh
Jia-Feng Chang
Mai-Szu Wu
Jing-Quan Zheng
Jian-Chiun Liou
Pre-Dialytic SpO2 Measured with a Wearable Device as a Predictor of Mortality in Patients with OSA and Chronic Kidney Disease
description Hypoxemia and obstructive sleep apnea (OSA) have been recognized as a threat to life. Nonetheless, information regarding the association between pre-dialytic pulse oximeter saturation (SpO2) level, OSA and mortality risks remains mysterious in patients with maintenance hemodialysis (MHD). Bioclinical characteristics and laboratory features were recorded at baseline. Pre-dialytic SpO2 was detected using a novel microchip LED oximetry, and the Epworth Sleepiness Scale (ESS) score greater than 10 indicated OSA. Non-adjusted and adjusted hazard ratios (aHRs) of all-cause and cardiovascular (CV) mortality were analyzed for pre-dialytic SpO2, OSA and potential risk factors. During 2152.8 patient-months of follow-up, SpO2 was associated with incremental risks of all-cause and CV death (HR: 0.90 (95% CI: 0.82–0.98) and 0.88 (95% CI: 0.80–0.98), respectively). The association between OSA and CV mortality was significant (HR: 3.19 (95% CI: 1.19–9.38). In the multivariate regression analysis, pre-dialytic SpO2 still had an increase in all-cause and CV death risk (HR: 0.88 (95% CI: 0.79–0.98), 0.82 (95% CI: 0.71–0.96), respectively). Considering the high prevalence of silent hypoxia in the post COVID-19 era, a lower pre-dialytic SpO2 level and severe OSA warn clinicians to assess potential CV risks. In light of clinical accessibility, the microchip LED oximetry could be developed as a wearable device within smartphone technologies and used as a routine screen tool for patient safety in the medical system.
format article
author Hsiao-Wei Lu
Pin-Hung Kuo
Cheuk-Sing Choy
Chih-Yu Hsieh
Jia-Feng Chang
Mai-Szu Wu
Jing-Quan Zheng
Jian-Chiun Liou
author_facet Hsiao-Wei Lu
Pin-Hung Kuo
Cheuk-Sing Choy
Chih-Yu Hsieh
Jia-Feng Chang
Mai-Szu Wu
Jing-Quan Zheng
Jian-Chiun Liou
author_sort Hsiao-Wei Lu
title Pre-Dialytic SpO2 Measured with a Wearable Device as a Predictor of Mortality in Patients with OSA and Chronic Kidney Disease
title_short Pre-Dialytic SpO2 Measured with a Wearable Device as a Predictor of Mortality in Patients with OSA and Chronic Kidney Disease
title_full Pre-Dialytic SpO2 Measured with a Wearable Device as a Predictor of Mortality in Patients with OSA and Chronic Kidney Disease
title_fullStr Pre-Dialytic SpO2 Measured with a Wearable Device as a Predictor of Mortality in Patients with OSA and Chronic Kidney Disease
title_full_unstemmed Pre-Dialytic SpO2 Measured with a Wearable Device as a Predictor of Mortality in Patients with OSA and Chronic Kidney Disease
title_sort pre-dialytic spo2 measured with a wearable device as a predictor of mortality in patients with osa and chronic kidney disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4f4ba22a47f44d2eb9f7c3df3f359cff
work_keys_str_mv AT hsiaoweilu predialyticspo2measuredwithawearabledeviceasapredictorofmortalityinpatientswithosaandchronickidneydisease
AT pinhungkuo predialyticspo2measuredwithawearabledeviceasapredictorofmortalityinpatientswithosaandchronickidneydisease
AT cheuksingchoy predialyticspo2measuredwithawearabledeviceasapredictorofmortalityinpatientswithosaandchronickidneydisease
AT chihyuhsieh predialyticspo2measuredwithawearabledeviceasapredictorofmortalityinpatientswithosaandchronickidneydisease
AT jiafengchang predialyticspo2measuredwithawearabledeviceasapredictorofmortalityinpatientswithosaandchronickidneydisease
AT maiszuwu predialyticspo2measuredwithawearabledeviceasapredictorofmortalityinpatientswithosaandchronickidneydisease
AT jingquanzheng predialyticspo2measuredwithawearabledeviceasapredictorofmortalityinpatientswithosaandchronickidneydisease
AT jianchiunliou predialyticspo2measuredwithawearabledeviceasapredictorofmortalityinpatientswithosaandchronickidneydisease
_version_ 1718413073682792448